Nasal Solution Liquid
NDC Package 84008-101-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Nasal Solution liquids is uses: *Congested nose andsinuses. This formulation utilizes a liquid delivery system. Marketed by Bullet Point Llc, this product is identified by NDC 84008-101 and is authorized under FDA application 505G(a)(3).

Identification & Billing

NDC Package Code
84008-101-01
Package Description
30 mL in 1 BOTTLE
Product Code
11-Digit Billing Format
84008010101
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Nasal Solution
Non-Proprietary Name
Nasal Solution
Substance Name
Povidone-iodine
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Nasal - Administration to the nose; administered by way of the nose.
Active Ingredient(s)
Usage Information
Uses: *Congested nose andsinuses. *lrritated and itchy nose. *Nasal exposure to bacteria,dust and other airbornecontaminants.

Regulatory & Marketing

Labeler Name
Bullet Point Llc
Product Type
Human Otc Drug
FDA Application #
505G(a)(3)
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
02-20-2024
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 84008-101-01 identifies a specific commercial package of 30 ml in 1 bottle of Nasal Solution, a human over the counter drug labeled by Bullet Point Llc. This liquid is formulated for nasal use and contains povidone-iodine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bullet Point Llc on February 20, 2024. The current certification is valid through December 31, 2027.

How is this Bullet Point Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 84008010101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
84008-101-01
11-Digit CMS (5-4-2)
84008-0101-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.